/
MedChemComm
Thioredoxin reductase, an emerging target for anticancer metallodrugs. Enzyme inhibition by cytotoxic gold(III) compounds studied with combined mass spectrometry and biochemical assays
- C. Gabbiani
- G. Mastrobuoni
- F. Sorrentino
- B. Dani
- M.P. Rigobello
- A. Bindoli
- M.A. Cinellu
- G. Pieraccini
- L. Messori
- A. Casini